Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Glioma × Dexamethasone × Clear all

Status

Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 97 Recurrence 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Neoplasms 12 Neoplasms, Plasma Cell 11 Leukemia 9 Lymphoma 8 Leukemia, Myeloid, Acute 8 Carcinoma, Non-Small-Cell Lung 8 Lymphoma, Non-Hodgkin 7 Vomiting 6 Lymphoma, Large B-Cell, Diffuse 6 Burkitt Lymphoma 6 Breast Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Nausea 5 Lung Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Immunoglobulin Light-chain Amyloidosis 3 Hematologic Neoplasms 3 Amyloidosis 3 Smoldering Multiple Myeloma 2 Renal Insufficiency 2 Oligodendroglioma 2 Myelodysplastic Syndromes 2 Mesothelioma 2 Lymphoma, B-Cell 2

Interventions

Temozolomide 21 Bevacizumab 10 Radiotherapy 5 Irinotecan 5 Carmustine 4 Topotecan 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Carboplatin 3 Aminolevulinic Acid 3 ribociclib 2 poly ICLC 2 fluoromisonidazole 2 fluorodopa F 18 2 carmustine, poliferprosan 20 drug combination 2 cabozantinib 2 TIC10 compound 2 Surgical Procedures, Operative 2 Standard of Care 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Panobinostat 2 O(6)-benzylguanine 2 Melphalan 2 Lomustine 2 Lacosamide 2 Filgrastim 2 Erlotinib Hydrochloride 2 Dynamic Contrast Enhanced Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04128774 2024-11-26

GBMdexaB

Amsterdam UMC, location VUmc

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡